Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 16.35 is 52% below its 5-year average of 34.35, near the low end of its 5-year range (16.35–62.09).
As of the fiscal period ended Tuesday, June 30, 2026. 47.37% below its 12-month average of 31.06.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 16.35.
QUICK RATIO (ACID-TEST)
16.35
QUICK RATIO (ACID-TEST) AVG TTM
31.06
QUICK RATIO (ACID-TEST) AVG 3Y
38.45
QUICK RATIO (ACID-TEST) AVG 5Y
34.35
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-47.37%
CURRENT VS 3Y AVG
-57.48%
CURRENT VS 5Y AVG
-52.42%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 623 covered companies
CURRENT VS SECTOR MEDIAN
+446.74%
vs the sector median at left
Janux Therapeutics, Inc.
Market Cap
$999.23M
Quick Ratio (Acid-Test)
16.35
TTM Avg
31.06
3Y Avg
38.45
5Y Avg
34.35
Market Cap
$1.00B
Quick Ratio (Acid-Test)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.02B
Quick Ratio (Acid-Test)
8.42
TTM Avg
11.89
3Y Avg
15.48
5Y Avg
17.00
Market Cap
$986.27M
Quick Ratio (Acid-Test)
16.33
TTM Avg
11.68
3Y Avg
16.13
5Y Avg
16.13
Market Cap
$1.02B
Quick Ratio (Acid-Test)
1.98
TTM Avg
1.08
3Y Avg
1.74
5Y Avg
1.96
Market Cap
$979.81M
Quick Ratio (Acid-Test)
3.76
TTM Avg
1.39
3Y Avg
1.76
5Y Avg
2.46
Market Cap
$978.16M
Quick Ratio (Acid-Test)
15.08
TTM Avg
22.50
3Y Avg
27.08
5Y Avg
27.08
Market Cap
$1.02B
Quick Ratio (Acid-Test)
1.44
TTM Avg
1.13
3Y Avg
1.10
5Y Avg
1.10
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | $999.23M | 16.35 | 31.06 | 38.45 | 34.35 |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $1.00B | N/A | N/A | N/A | N/A |
| Immatics N.V. (IMTX)vs › | $1.01B | 7.54 | 10.49 | 6.85 | 5.34 |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $1.02B | 8.42 | 11.89 | 15.48 | 17.00 |
| Aktis Oncology, Inc. (AKTS)vs › | $986.27M | 16.33 | 11.68 | 16.13 | 16.13 |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.02B | 1.98 | 1.08 | 1.74 | 1.96 |
| MeiraGTx Holdings plc (MGTX)vs › | $979.81M | 3.76 | 1.39 | 1.76 | 2.46 |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $978.16M | 15.08 | 22.50 | 27.08 | 27.08 |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.02B | 1.44 | 1.13 | 1.10 | 1.10 |
| Castle Biosciences, Inc. (CSTL)vs › | $1.05B | 5.85 | 6.12 | 6.56 | 10.14 |
Quick Ratio
16.35
Excludes inventory
Current Ratio
16.35
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 16.35 |
| 2026-03-31 | 17.01 |
| 2025-12-31 | 39.04 |
| 2025-09-30 | 35.86 |
| 2025-06-30 | 47.03 |
| 2025-03-31 | 58.47 |
| 2024-12-31 | 59.21 |
| 2024-09-30 | 38.80 |
| 2024-06-30 | 57.34 |
| 2024-03-31 | 62.09 |
| 2023-12-31 | 26.80 |
| 2023-09-30 | 24.55 |
| 2023-06-30 | 17.28 |
| 2023-03-31 | 19.95 |
| 2022-12-31 | 20.14 |
| 2022-09-30 | 21.08 |
| 2022-06-30 | 27.56 |
| 2022-03-31 | 29.14 |
| 2021-12-31 | 29.46 |
| 2021-09-30 | 31.24 |
| 2021-06-30 | 43.09 |
| 2021-03-31 | 10.36 |
| 2020-12-31 | 5.05 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
